Researchers have found a protein that seems to protect brain cells …
WEBJul 24, 2024 · A study of 48 post-mortem brains found a protein that appears to protect brain cells from Alzheimer's — even in people who had significant amounts of amyloid plaques in their brains.
Alzheimer's News -- ScienceDaily
WEB2 days ago · Stay updated on the latest news and discoveries about Alzheimer's disease and related dementias. Read about the causes, symptoms, treatments, and prevention of this neurodegenerative condition...
FDA fully approves Leqembi, first drug shown to slow Alzheimer's ...
WEBJul 6, 2023 · The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's disease. The action means that Leqembi, whose generic name is lecanemab, should be widely...
A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, …
WEBJul 28, 2024 · The results, presented Sunday at the Alzheimer’s Association International Conference in Philadelphia, are the latest milestone in the search for affordable and accessible ways to diagnose...
First Alzheimer’s drug to slow disease progression gets full FDA ...
WEBJul 7, 2023 · CNN — The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease.
New Drug Approved for Early Alzheimer’s - The New York Times
WEBJul 2, 2024 · The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted with hope, disappointment and skepticism.
Leqembi and Alzheimer’s: What to Know About the New Drug, …
WEBJun 10, 2024 · Alzheimer’s is the most common form of dementia, but much remains unknown about this daunting disease. How is Alzheimer’s diagnosed? What causes …
New Alzheimer's studies reveal disease biology, risk for …
WEB3 days ago · The failure to diagnose Alzheimer's disease, the most common form of dementia in the elderly, at an early stage of molecular pathology is considered a major reason why treatments fail in clinical ...
FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment
WEBJan 6, 2023 · Leqembi is a new medication that reduces amyloid beta plaque in the brain, a marker of Alzheimer's disease. It is approved via the Accelerated Approval pathway for patients with mild cognitive...
Start of new era for Alzheimer’s treatment — Harvard Gazette
WEBJun 5, 2023 · A drug that lowers amyloid beta in the brain has been shown to slow cognitive and functional decline in mild Alzheimer's disease. Learn more about the trial results, the mechanism of action, and the future directions of research from an …